Showing results (1-10 of 279) with videos related to
Sort By:
Pageof 28
Frontiers in Oncology|January 31, 2022
Interactions Between Anti-Angiogenic Therapy and Immunotherapy in GlioblastomaSaket Jain, Eric J Chalif, Manish K AghiJournal of Neurosurgery|February 16, 2022
Effect of facility volume on giant pituitary adenoma neurosurgical outcomesEric J Chalif, William T Couldwell, Manish K AghiNeurosurgery|January 13, 2023
Neurosurgical Outcomes for Pediatric Central Nervous System Tumors in the United StatesEric J Chalif, Ramin A Morshed, Taemin Oh, et al.Journal of Neurosurgery|May 10, 2022
Pituitary adenoma in the elderly: surgical outcomes and treatment trends in the United StatesEric J Chalif, Ramin A Morshed, Jacob S Young, et al.Journal of Neurosurgery|July 6, 2023
High-volume facilities are not always low risk: comparing risk-standardized mortality rates versus facility volume as quality measures in surgical neuro-oncologyEric J Chalif, Jacob S Young, Genaro R Villa, et al.Nature Clinical Practice. Endocrinology & Metabolism|August 20, 2008
Management of recurrent and refractory Cushing diseaseManish K AghiNeurosurgery Clinics of North America|March 24, 2012
Pseudoprogression and treatment effectArman Jahangiri, Manish K AghiBiochimica Et Biophysica Acta|November 10, 2011
Biomarkers predicting tumor response and evasion to anti-angiogenic therapyArman Jahangiri, Manish K AghiNature Reviews. Clinical Oncology|October 7, 2009
New advances that enable identification of glioblastoma recurrenceIsaac Yang, Manish K AghiPageof 28